Separase 是一种半胱氨酸蛋白酶和内肽酶,属于 CD clan 蛋白酶家族。Separase 可通过切割黏连蛋白的 Scc1/Rad21 亚基,促使姐妹染色单体分离。Separase 也可切割 Mcd1。其活性受到紧密调控,与 securin、cyclin B1/CDK1 等存在复杂的抑制性相互作用,同时也受 PP2A 等调节。Separase 与多种癌症密切相关。在乳腺癌中,其异常表达可预测患者预后,高有丝分裂 Separase 预示不良预后,而弥漫性 Separase 则与生存优势相关;在卵巢癌中,ESPL1 (编码 Separase) 在高级别浆液性卵巢癌中差异表达,且表达水平高于正常卵巢组织;在小鼠模型中,过表达 Separase 可诱导乳腺上皮细胞非整倍体和肿瘤发生。此外,Separase 还参与酵母细胞的凋亡过程[1][2][3][4][5][6][7]。
Separase is a cysteine protease and endopeptidase belonging to the CD clan protease family. Separase can promote sister chromatid separation by cleaving the Scc1/Rad21 subunit of cohesin. Separase can also cleave Mcd1. Its activity is tightly regulated, and it has complex inhibitory interactions with securin, cyclin B1/CDK1, etc., and is also regulated by PP2A, etc. Separase is closely related to a variety of cancers. In breast cancer, its abnormal expression can predict the prognosis of patients. High mitotic Separase indicates a poor prognosis, while diffuse Separase is associated with a survival advantage. In ovarian cancer, ESPL1 (encoding Separase) is differentially expressed in high-grade serous ovarian cancer, and the expression level is higher than that in normal ovarian tissue. In mouse models, overexpression of Separase can induce aneuploidy and tumorigenesis of mammary epithelial cells. In addition, Separase is also involved in the apoptosis process of yeast cells[1][2][3][4][5][6][7].
Sepin-1 是一种有效的分离酶 (separase) 抑制剂(IC50 值为 14.8 µM),可抑制细胞增殖、迁移和伤口愈合,降低 FoxM1 蛋白和 mRNA 水平的表达,并具有抗肿瘤活性。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号